戻る Agenda
Round Table: What are Expectations for “Adaptive Licensing"?
Session Chair(s)
Kazuhiko Mori, PHD, MSC
Former Executive Director
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Yoshihiko Ono, RPH
Regulatory Executive Advisor
MSD K.K., Japan
Speaker(s)
Implementation of Adaptive Licensing in Europe
Francesco Pignatti, MD
European Medicines Agency, Netherlands
Scientific Adviser for Oncology
Perspective on the Regulatory Schema of the Adaptive Licensing for Pharmaceuticals
Daisaku Sato, PHD, MPHARM, RPH
Ministry of Health, Labour and Welfare, Japan
Councilor for Pharmaceutical Affairs
Moving Forward To New Paradigm~ Adaptive Approach ~
Hiromichi Shirasawa, MD
MSD K.K., Japan
Vice President and Executive Officer, Head of Japan Development